Dates and Time
Friday January 10th: 6.00 PM - 10.00 PM
Saturday January 11th: 9.00 AM - 10.00 PM
Sunday January 12th: 9.00 AM - 5.00 PM
Location
Stanford Center for Genetics and Personalized Medicine
3165 Porter Dr
Palo Alto, CA 94304
Google Map
Data
Data access is available for invited participants. Please apply here.
-
Timeline and Summary
-
Nutritional Supplement Protocol
-
CT Scans / PET Scans
-
Genetic / Molecular Oncology Reports
-
Lab Reports and Doctors Notes
-
Visit Summaries @ Memorial Sloan Kettering
-
Pathology Reports
-
Neoepitope Prediction and Peptide Selection
-
MSK-IMPACT Report
-
MSK BAM files
-
Whole Exome Sequencing from CeGat
-
Raw CeGat sequence data in FastQ
-
Aligned CeGat reads in BAM format
-
Variant lists in VCF format
-
Annotated variant lists
DNA and RNA Notes:
1) "A depth coverage of >120 sequence reads per base was attained for 65.09% of the targeted regions. The records denote that the detection of low frequency variation may be impaired and recommends sequencing a new sample." 2) "The quality and quantity of the tumor RNA from the sample 05-2019 was not sufficient for RNA sequencing." We are pursuing additional sequencing however no new data will be available for this event.
Computable Medical Records
Thank you Jason Chin from DNAnexus for putting Leila's medical records in machine readable format using Amazon Comprehend Medical.
People
Leila
Patient
Leila is the Founder and CEO of Samasource, Samaschool, and LXMI, enterprises that #givework to low-income people around the world using cutting-edge social enterprise models in AI/machine learning, digital freelancing, and clean skincare, respectively.
In April 2019 Leila was diagnosed with vulvar epithelioid sarcoma, an extremely rare and aggressive cancer.
Dr. Michael Castro
Leila's Oncologist
Keynote Speaker
Dr. Michael Castro is Leila's medical oncologist. He will deliver the Keynote address on Saturday morning January 11th covering Leila's case summary, and an introduction to Epithelioid Sarcoma. Dr. Castro is a board-certified neuro & medical-oncologist with more than 25-year experience in direct patient care, clinical research, and program development. His key interests include immunotherapy of cancer and precision medicine, i.e. the use of genomic testing and biomarkers to develop more effective and less toxic treatments for cancer patients.
Dr. Michael Snyder
Stanford W. Ascherman Professor and Chair, Department of Genetics
Director, Center for Genomics and Personalized Medicine
Dr. Michael Snyder received his Ph.D. training at the California Institute of Technology and carried out postdoctoral training at Stanford University. He is a leader in the field of functional genomics and proteomics, and one of the major participants of the ENCODE project.
His laboratory study was the first to perform a large-scale functional genomics project in any organism, and has developed many technologies in genomics and proteomics. These including the development of proteome chips, high resolution tiling arrays for the entire human genome, methods for global mapping of transcription factor binding sites (ChIP-chip now replaced by ChIP-seq), paired end sequencing for mapping of structural variation in eukaryotes, de novo genome sequencing of genomes using high throughput technologies and RNA-Seq. These technologies have been used for characterizing genomes, proteomes and regulatory networks.
Seminal findings from the Snyder laboratory include the discovery that much more of the human genome is transcribed and contains regulatory information than was previously appreciated, and a high diversity of transcription factor binding occurs both between and within species.
Diana Saville
CCO, BrainMind
MC
Diana Saville is a close friend of Leila and has been involved in all aspects of her care. Diana is the founding CCO of BrainMind, an impact accelerator for brain science. Diana is an expert in creative communication of complex scientific concepts. She develops multimedia educational programs for doctors, investors, researchers, and patients, and organizes international expert summits on scientific and medical topics.
Aaron Marks Horning
Postdoctoral Research Scholar - Genetics, Stanford
Aaron Horning is a Postdoctoral Research Scholar in Genetics at the Snyder Lab. He is working on generating additional mets data from Leila's sample and will give a presentation on what he did and data that was able to be produced. Aaron studied Biochemistry an Cell Biology at UCSD and received his PhD at UT Health San Antonio in Biomedical Sciences, where he studied cell-free DNA methylation and single-cell RNA sequencing to predict biochemical recurrence in prostate cancer.
Benjamin Rolnik
Director - Stanford Healthcare Innovation Lab
Co-MC and Co-Organizer
Benjamin Rolnik is Director of Stanford's Healthcare Innovation Lab. Ben led Stanford's involvement in this case and facilitated the SCGPM venue. He will give a welcoming talk at the event. Ben has worked with some of the biggest YouTube Stars & personal development leaders in the world, launched 2 technology companies, and founded Integral Fitness, a bicoastal millennial personal development organization. Combining his experience in business with his research at Stanford & UCLA investigating Health, Happiness, Wellbeing, Stress & Resilience, he is engineering universal techniques that can assist anyone in living a life they love.
Ariel Ganz
Postdoctoral Fellow, Stanford
Co-Organizer
Ariel Ganz is a Postdoctoral Fellow in Genetics working with the Chair of Genetics and Personalized Medicine at Stanford, Dr. Michael Snyder. My work applies Precision Health techniques for understanding and improving human wellness. She has a PhD in Molecular Nutrition with a focus on Chemistry, Biochemistry, and Nutrigenetics from Cornell University. Ariel is excited about psychoneuroimmunology and personalized approaches to health, nutrition, wellness, and personal growth.
David Gennert
PhD Candidate, Genetics, Stanford
Research Summary Lead Author
Dave Gennert received his B.S. in Biology from Tufts University and is currently pursuing his Ph.D. in Genetics at Stanford University. His research explores transcriptional and epigenetic changes associated with immune cell function and dysfunction. He is excited about communicating with the public about science and, as a producer and host for the science news podcast Goggles Optional, making sure everyone gets as excited about new scientific breakthroughs as he does.
Alivia Blount
Research Summary Co-Author
Alivia Blount is a writer with a background in computer science and machine learning. She has extensive medical volunteer experience and is a past participant in Research to the People's patient cases.
Drew Merit
Graphic Illustrator
Drew Merit is a graphic facilitator, advisor, and performing artist. He leverages visual thinking to augment creative collaboration in academic settings. Drew has taught Visual Thinking and Communication at the Stanford Hasso Plattner Institute of Design (d.school). He has also spoken at the California College of the Arts in San Francisco and facilitated sessions at Google, Citrix, and Mozilla.
Celestine Schnugg
Investor
Friend of Leila
Celestine Schnugg is an investor and advisor to deeply technical, under networked founders building companies of consequence at Boom Capital. Five years at Eric Schmidt & Dror Berman's VC, Innovation Endeavors. Operating experience at Apple. Innovation advisor to British Airways. Top 100 Most Innovative People award in 2015. Celestine's efforts to advance research for Leila led to Research to the People organizing this case.
Agenda
January 10th: 18.00 - 22.00
18.00 - Dinner
18.30 - Welcome, Introductions, Weekend Objectives
19.30 - Setup, Preliminary Group Formation and Case Discussion
January 11th: 9.00 - 22.00
9.00 - Breakfast
9.15 - Dr. Michael Castro Case Presentation and Keynote Address
10.00 - Aaron Horning PhD will give an update on the sample Stanford Received.
12.00 - Lunch
18.00 - Dinner
January 12th: 9.00 - 17.00
9.00 - Breakfast
12.00 - Lunch
15.30 - Results Presentations
Case Summary
Please Join Case for full Summary and Timeline.